| | | | | |
| $31,7510 | -0,31 % | $280,50M | $9,73K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,0800 | +0,14 % | $280,16M | $22,19K | |
TSI TCW Strategic Income Fund, Inc. | $4,3900 | +0,23 % | $279,70M | $69,14K | |
PAII Pyrophyte Acquisition Corp. II | $10,2850 | +0,15 % | $279,21M | $7,000 | |
| $14,3750 | +2,68 % | $279,07M | $85,11K | |
YDES YD Bio Limited Ordinary Shares | $4,4440 | -4,64 % | $279,07M | $4,64K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $10,0450 | +0,55 % | $278,71M | $5,97K | |
RWAY Runway Growth Finance Corp. Common Stock | $6,5350 | -0,53 % | $278,70M | $70,07K | |
JILL J.Jill, Inc. Common Stock | $19,7080 | -1,51 % | $278,69M | $5,71K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,1050 | +1,38 % | $278,19M | $214,69K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | -0,05 % | $278,12M | $7,60K | |
ACV Virtus Diversified Income & Convertible Fund | $26,5180 | +0,22 % | $278,09M | $17,56K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9950 | +0,25 % | $277,93M | $104,16K | |
| $1,4150 | +1,07 % | $277,83M | $45,26K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $2,9710 | -0,97 % | $277,66M | $14,35K | |
